Threonine-Proline-Chimeras, A Valuable Building Block for Peptidomimetic Design: A Review

E-ISSN： 1875-6646|12|3|221-228

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.12, Iss.3, 2016-06, pp. : 221-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Amino Acid Proline-Chimeras: Role in Biological Active Compounds and Drug Design)

Current Bioactive Compounds, Vol. 12, Iss. 3, 2016-06 ,pp. : 134-135

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Strategies for Lysine-Proline Chimeras: An Overview

Current Bioactive Compounds, Vol. 12, Iss. 3, 2016-06 ,pp. : 191-199

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Synthetic Approaches for the Synthesis of Alanine-Proline Chimeras

Current Bioactive Compounds, Vol. 12, Iss. 3, 2016-06 ,pp. : 207-220

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery

Current Bioactive Compounds, Vol. 12, Iss. 3, 2016-06 ,pp. : 161-167

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Peptidomimetic Based DPP-IV Inhibitors, Devoid of CYP Liabilities

Letters in Drug Design & Discovery, Vol. 9, Iss. 9, 2012-11 ,pp. : 867-873

Bentham Science Publishers

Access to resources Recommend Favorite